AI
AJU IB Investment Co., Ltd.
13F filer · CIK 0001710065Reported Jul 16, 2026
Net seller this quarter
13F portfolio value$0U.S. long equity reported on 13F
Positions00 new · 6 closed
Net flow last quarter-$31.8MBuys minus sells
Top 10 positions weightNot reportedConcentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Jul 16, 20260 positions | |||||
| Q1 2026Reported May 8, 20266 positions | |||||
| AACLXArcellx, Inc. | $25.7M | 84.07% | 0.38% | Not reported | Q1 2022 |
| $1.64M | 5.36% | 0.02% | Not reported | Q4 2020 | |
| $1.54M | 5.05% | 1.45% | Not reported | Q4 2020 | |
| $846K | 2.77% | 1.78% | 0.0% | Q4 2021 | |
| $436K | 1.43% | 0.11% | Not reported | Q4 2020 | |
| $401K | 1.31% | 0.82% | 0.0% | Q4 2021 | |
| Q4 2025Reported Feb 10, 20267 positions | |||||
| AACLXArcellx, Inc. | $14.6M | 63.94% | 0.39% | -78.7% | Q1 2022 |
| $4.14M | 18.18% | 14.28% | Not reported | Q4 2021 | |
| $1.53M | 6.71% | 0.02% | -95.7% | Q4 2020 | |
| $1.49M | 6.56% | 1.28% | Not reported | Q4 2020 | |
| $427K | 1.88% | 14.74% | Not reported | Q4 2021 | |
| RTRAPTRAPT Therapeutics, Inc. | $421K | 1.85% | 0.04% | Not reported | Q4 2020 |
| $202K | 0.89% | 0.20% | Not reported | Q4 2020 | |
| Q3 2025Reported Nov 6, 20257 positions | |||||
| AACLXArcellx, Inc. | $86M | 74.71% | 1.81% | Not reported | Q1 2022 |
| $25.9M | 22.47% | 0.64% | Not reported | Q4 2020 | |
| $1.8M | 1.57% | 1.28% | Not reported | Q4 2020 | |
| $596K | 0.52% | 1.29% | Not reported | Q4 2021 | |
| $377K | 0.33% | 1.80% | Not reported | Q4 2021 | |
| RTRAPTRAPT Therapeutics, Inc. | $321K | 0.28% | 0.08% | Not reported | Q4 2020 |
| $153K | 0.13% | 0.21% | Not reported | Q4 2020 | |
Premium opens every quarter this fund has filed